| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PANTOPRAZOLE SODIUM | 219087 | 002 | ANDA | PANTOPRAZOLE SODIUM | TABLET, DELAYED RELEASE;ORAL | EQ 40MG BASE | No | No | 2025/01/16 | 2025/01/16 | GRAVITI PHARMS | Prescription |
| PANTOPRAZOLE SODIUM | 217458 | 001 | ANDA | PANTOPRAZOLE SODIUM | FOR SUSPENSION, DELAYED RELEASE;ORAL | EQ 40MG BASE | No | No | 2025/03/31 | 2025/03/31 | CIPLA | Prescription |
| PANTOPRAZOLE SODIUM | 217923 | 001 | ANDA | PANTOPRAZOLE SODIUM | FOR SUSPENSION, DELAYED RELEASE;ORAL | EQ 40MG BASE | No | No | 2025/03/31 | 2025/03/31 | AUROBINDO PHARMA LTD | Prescription |
| PANTOPRAZOLE SODIUM | 219230 | 001 | ANDA | PANTOPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | EQ 40MG BASE/VIAL | No | No | 2025/03/31 | 2025/03/31 | ALEMBIC | Prescription |
| PANTOPRAZOLE SODIUM | 215074 | 001 | ANDA | PANTOPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | EQ 40MG BASE/VIAL | No | No | 2025/05/16 | 2025/05/16 | DEVA HOLDING AS | Prescription |